Literature DB >> 7827781

Improved functional survival of human islets of Langerhans in three-dimensional matrix culture.

M D Brendel1, S S Kong, R Alejandro, D H Mintz.   

Abstract

The current study evaluates functional survival of human islets maintained in tissue culture for up to 4 wk in suspension media (CMRL-1066 with supplements) and contrasts these results with immobilizing three-dimensional matrices (agarose or alginate). The absolute number and volume of islets retrieved from agarose is significantly higher after two and four wk of culture compared to conventional free-floating media. In vitro function of islets, assessed by insulin/DNA content, insulin secretion into the culture media over 24 h and glucose-theophylline stimulated insulin release in a dynamic perifusion system, was not significantly different between free-floating and matrix preserved islets. In vivo islet function was evaluated by the effectiveness for reversal of insulin-dependent diabetes mellitus by transplantation of the islets under the kidney capsule of nude mice. Although adequate insulin responses to glucose were seen after culture in conventional or matrix media, only agarose embedded islets were consistently able to induce normoglycemia in diabetic recipients after 14 days of culture. Additional transplantation experiments defined the threshold level required to reverse diabetes to be between 1,000 and 1,500 agarose preserved islets. Our data suggest improved engraftment of human islets after agarose culture. This culture method may be of benefit for the accumulation of functionally competent human islets, thus facilitating the implementation of clinical protocols that utilize freshly isolated islets from multiple donors without the need for cryopreservation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7827781     DOI: 10.1177/096368979400300510

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  9 in total

Review 1.  Tissue engineering approaches to cell-based type 1 diabetes therapy.

Authors:  Luke D Amer; Melissa J Mahoney; Stephanie J Bryant
Journal:  Tissue Eng Part B Rev       Date:  2014-04-22       Impact factor: 6.389

2.  Influence of heme oxygenase-1 gene transfer on the viability and function of rat islets in in vitro culture.

Authors:  Xiao-Bo Chen; Yong-Xiang Li; Yang Jiao; Wei-Ping Dong; Ge Li; Jing Chen; Jian-Ming Tan
Journal:  World J Gastroenterol       Date:  2007-02-21       Impact factor: 5.742

3.  Enhanced function of pancreatic islets co-encapsulated with ECM proteins and mesenchymal stromal cells in a silk hydrogel.

Authors:  Nicolynn E Davis; Liese N Beenken-Rothkopf; Annie Mirsoian; Nikola Kojic; David L Kaplan; Annelise E Barron; Magali J Fontaine
Journal:  Biomaterials       Date:  2012-07-04       Impact factor: 12.479

4.  c-Jun N-terminal kinase 1 is deleterious to the function and survival of murine pancreatic islets.

Authors:  J L Varona-Santos; A Pileggi; R D Molano; N Y Sanabria; A Ijaz; M Atsushi; H Ichii; R L Pastori; L Inverardi; C Ricordi; A Fornoni
Journal:  Diabetologia       Date:  2008-10-14       Impact factor: 10.122

5.  Inhibition of c-jun N terminal kinase (JNK) improves functional beta cell mass in human islets and leads to AKT and glycogen synthase kinase-3 (GSK-3) phosphorylation.

Authors:  A Fornoni; A Pileggi; R D Molano; N Y Sanabria; T Tejada; J Gonzalez-Quintana; H Ichii; L Inverardi; C Ricordi; R L Pastori
Journal:  Diabetologia       Date:  2007-12-08       Impact factor: 10.122

6.  Sustained insulin secretory response in human islets co-cultured with pancreatic duct-derived epithelial cells within a rotational cell culture system.

Authors:  H E Murray; M B Paget; C J Bailey; R Downing
Journal:  Diabetologia       Date:  2009-01-08       Impact factor: 10.122

7.  Islet product characteristics and factors related to successful human islet transplantation from the Collaborative Islet Transplant Registry (CITR) 1999-2010.

Authors:  A N Balamurugan; B Naziruddin; A Lockridge; M Tiwari; G Loganathan; M Takita; S Matsumoto; K Papas; M Trieger; H Rainis; T Kin; T W Kay; S Wease; S Messinger; C Ricordi; R Alejandro; J Markmann; J Kerr-Conti; M R Rickels; C Liu; X Zhang; P Witkowski; A Posselt; P Maffi; A Secchi; T Berney; P J O'Connell; B J Hering; F B Barton
Journal:  Am J Transplant       Date:  2014-10-02       Impact factor: 8.086

8.  Transporting cells over several days without dry-ice.

Authors:  Sally P Wheatley; Denys N Wheatley
Journal:  J Cell Sci       Date:  2019-11-01       Impact factor: 5.285

9.  Development of in vitro 3D TissueFlex® islet model for diabetic drug efficacy testing.

Authors:  Zhaohui Li; He Sun; Jianbin Zhang; Haijiao Zhang; Fanyu Meng; Zhanfeng Cui
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.